WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)

Market Cap	129.51B +62.1%
Revenue (ttm)	106.44B +3.6%
Net Income	4.97B +3.8%
EPS	376.00 +3.9%
Shares Out	13.20M
PE Ratio	26.09
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	156,762
Average Volume	118,238
Open	9,570.00
Previous Close	9,570.00
Day's Range	9,310.00 - 9,850.00
52-Week Range	6,200.00 - 11,950.00
Beta	0.85
RSI	66.14
Earnings Date	n/a

About KOSDAQ:330350

WITHUS PHARMACEUTICAL Co.,LTD. engages in the production and sale of pharmaceutical products in South Korea. It offers circulatory agents, endocrine cost medications, osteoporosis treatment products, antithrombotic medicines, central nervous system agents, digestive tract medications, respiratory/skin preparations, musculoskeletal medications, antibiotics, antifungal and antiviral drugs, genitourinary tract medications, psychotropic agents, and other products. The company was previously known as Withers Medipharm Co. , Ltd. and changed its name...

• Industry: Pharmaceutical Preparations
• Founded: 2004
• Employees: 121
• Stock Exchange: KOSDAQ
• Ticker Symbol: 330350

Financial Performance

In 2025, KOSDAQ:330350's revenue was 106.44 billion, an increase of 3.62% compared to the previous year's 102.72 billion. Earnings were 4.97 billion, an increase of 3.81%.